The nasal delivery of peptides and proteins.
Many drugs of the future will be therapeutically active peptides and proteins developed through recombinant-DNA technology. A major factor limiting their exploitation is the current lack of appropriate non-parenteral delivery systems. Nasal systems incorporating absorption enhancers may provide a convenient, efficient means of administering protein and peptide therapeutics.
Department of Pharmaceutical Sciences, Nottingham University, UK.
L
L
Illum
D000281:Administration, Intranasal; D010455:Peptides / Q000008:administration & dosage*; D011506:Proteins / Q000008:administration & dosage*
D010455:Peptides; D011506:Proteins